Searchable abstracts of presentations at key conferences in endocrinology

ea0080OC1 | Oral Communications | UKINETS2021

Incidence, prevalence of survival of neuroendocrine neoplasia in England 1995–2018

White Benjamin E , Chandrakumaran Kandiah , Wong Kwok , Rous Brian , Bouvier Catherine , Van Hemelrijck Mieke , Srirajaskanthan Rajaventhan , Ramage John K

Introduction: Incidence of neuroendocrine neoplasia (NEN) is rising worldwide. The National Cancer Registry and Analysis Service allows accurate study of NEN in England. Aim: Calculate incidence and prevalence of NEN in England from 1995-2018. Calculate site-specific survival with multivariate analysis. Method: A population-based retrospective cohort study was performed. Data requested from NCRAS were reviewed by a steering group r...

ea0080p3 | Abstracts | UKINETS2021

Sex differences and survival of neuroendocrine neoplasia in England 2012–2018

White Benjamin E , Chandrakumaran Kandiah , Wong Kwok , Rous Brian , van Hemelrijck Mieke , Srirajaskanthan Rajaventhan , Ramage John K

Introduction: Sex differences have been noted at different sites of Neuroendocrine Neoplasia in previous registry studies across different countries. Analysis of National Cancer Registry and Analysis Service (NCRAS) data can help to clarify the significance and importance of this factor in England. Aim: To examine neuroendocrine neoplasia incidence and survival by sex, site and stage. Method: A population-based, cohort study was pe...

ea0081ep625 | General Endocrinology | ECE2022

The development of a GLP protocol for the measurement of 17β-estradiol and testosterone in the H295R steroidogenesis assay, Test No 456

Murray Carol , McIntyre Angela , McKeever Connor , White Rebecca , McBrinn Rachel , Light Victoria , Brown Susan , Robinson Aron , Clark Graeme , Bingham Tilly

Regulators are concerned about the potential for environmental chemicals such as agrochemicals and their metabolites to perturb hormone systems. This has led to recommendations for the testing of potential endocrine disrupting chemicals1. The Steroidogenesis H295R assay is an in vitro cell model used to investigate compound effects on steroid hormone biosynthesis, specifically 17β-estradiol (E2) and testosterone (T). The human H295R adreno-carcinoma ce...

ea0086p70 | Metabolism, Obesity and Diabetes | SFEBES2022

Liver specific microparticles to improve islet transplantation outcomes in Type 1 diabetes

Walker Sophie , Lee I-ning , Gadd Victoria , Mellis David , Henderson John , Judge Amelia , Forbes Stuart , White Lisa , Forbes Shareen

Background: Islet transplant into the liver is a therapy for type 1 diabetes patients experiencing severe hypoglycaemia or impaired hypoglycaemic awareness. Widespread use is not currently considered due to the requirement for immunosuppression for the lifetime of the graft, and the attrition in graft function over the following 1-5 years. Following transplant into the liver, inflammation results in >60% islet loss, with few patients achieving insulin independence. The liv...

ea0087p1 | Poster Presentations | UKINETS2022

Second primary malignancies in patients with a neuroendocrine neoplasm in England

Russell Beth , E White Benjamin , Rous Brian , Wong Kwok , Bouvier Catherine , Srirajaskanthan Rajaventhan , Van Hemelrijck Mieke , K Ramage John

Background: Patients with neuroendocrine neoplasms (NENs) may often develop other malignancies. This study aimed to identify the frequency at which these second non-NEN malignancies occurred in England.Methods: Data was extracted from the National Cancer Registration and Analysis Service (NCRAS) on all patients diagnosed with a NEN at one of eight NEN site groups between 2012-2018: appendix, caecum, colon, lung, pancreas, rectum, small intestine and stom...

ea0090p456 | Reproductive and Developmental Endocrinology | ECE2023

Nurse-Led Care for Transgender and Gender Diverse Individuals: A Cross-Sectional Study of International Context and Practice

Greenspan Debra , White Bradley P. , Bobrowich Eli G. , Carruthers Paul , Ducar Dallas , Ernstsson Camilla , Barrett Sophia , Dwyer Andrew

Introduction: Gender minorities, including transgender and gender diverse (TGD) individuals face health disparities and significant barriers in accessing healthcare. Lack of access to providers knowledgeable in TGD health needs is the single greatest barrier to care. Existing literature on TGD care has almost exclusively focused on physicians and there is scant literature on the role of nurses. We aimed to describe exemplars of nurse-led TGD care internationally to better unde...

ea0066p16 | Diabetes 1 | BSPED2019

Improving the rate of completion of 7 care processes at a busy district general hospital by using quality improvement methodology

Kassab Ahmed , Rawal Sanjay , Meijgaarden Birgit Van , Ahmed Shahida , Francks Ruth , White Lynn , Daniel Elizabeth , Hunt Laura

Background: The NPDA has been providing annual audit reports to paediatric units in UK from 2003 and a compliance report for 7 care processes since 2016–2017. Over the years the focus on the type of data and implications of data has changed and become more focused especially after introduction of BPT and PEER review. The paediatric diabetes services at Basildon and Thurrock University Hospitals (BTUH) were identified as negative outliers in 2016–2017 NPDA report. A Q...

ea0044p39 | Adrenal and Steroids | SFEBES2016

Salivary cortisone is a potential surrogate for serum cortisol measurement

Adam Safwaan , Minder Anna , Cottrell Elizabeth , Davies Alison , Meredith Suzanne , Preziosi Richard , Keevil Brian , Higham Claire , White Anne , Trainer Peter

Introduction: Hydrocortisone therapy in adrenal insufficiency and medical management of Cushing’s syndrome requires accurate monitoring of glucocorticoid status. Currently, this necessitates admitting patients to hospital for serial measurements of serum cortisol. From previous studies in Cushing’s, the goal of medical therapy is a mean (based on five samples) serum cortisol of 150–300 nmol/l, which is known to equate to a normal cortisol production rate. Saliva...

ea0044p177 | Obesity and Metabolism | SFEBES2016

Glucocorticoid treatment rapidly increases AgRP and food intake with delayed effects on other metabolic systems

Harno Erika , Davies Alison , Allen Tiffany-Jayne , Sefton Charlotte , Wray Jonathan R , Ramamoorthy Thanuja Gali , Coll Anthony P , White Anne

Glucocorticoids are widely prescribed therapeutic agents, however long term treatment can cause increased morbidity from adverse metabolic events, including weight gain and hyperglycaemia. The mechanisms and site of action which underpin these side-effects are not fully understood. The aim of this study was to characterise phenotypic, biochemical and neurohormonal responses in mice administered corticosterone, with a particular focus on changes seen in the early stages of chro...

ea0044p192 | Obesity and Metabolism | SFEBES2016

RNA-seq of mouse arcuate nuclei reveals pathways perturbed by glucocorticoid treatment

Wray Jonathan , Harno Erika , Davies Alison , Sefton Charlotte , Allen Tiffany-Jayne , Lam Brian Y.H. , Yeo Giles S.H. , White Anne

Glucocorticoids (GCs) are widely prescribed to treat a number of inflammatory and autoimmune conditions. However, patients receiving GCs often develop adverse metabolic effects such as hyperphagia leading to weight gain and hyperglycaemia. Little is known about the central effects of GCs; however they can act in the hypothalamic arcuate nucleus (ARC), a region involved in the integration of other energy regulatory hormones such as leptin, insulin and ghrelin. Therefore, the ai...